Hospital-acquired pneumonia in Japan may have a better mortality profile than HAP in the United States: A retrospective study

Journal of Infection and Chemotherapy

Volumn 18, Issue 5, 2012, Pages 734-740

  Iwata, Kentaro ^a   Igarashi, Wataru ^a   Honjo, Midori ^b   Oka, Hideaki ^c   Oba, Yuichiro ^a   Yoshida, Hiroyuki ^a   Ohji, Goh ^a   Shimada, Toshihiko ^d  

^a KOBE UNIVERSITY HOSPITAL   (Japan)

^b Accerise Inc   (Japan)

^c KANTO ROSAI HOSPITAL   (Japan)

^d RAKUWAKAI OTOWA HOSPITAL   (Japan)

Author keywords

Gram staining; Hospital acquired pneumonia; Prediction rule

Indexed keywords

AGED; BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL ARTICLE; CLINICAL EVALUATION; COMORBIDITY; CONFERENCE PAPER; DISEASE SEVERITY; FEMALE; GRAM STAINING; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; INTENSIVE CARE UNIT; JAPAN; LUNG LAVAGE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; UNIVERSITY HOSPITAL; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84871396016     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0411-x     Document Type: Conference Paper

References (21)

1. Niederman MS. Guidelines for the management of respiratory infection: why do we need them, how should they be developed, and can they be usefulCurr Opin Pulm Med. 1996;2:161-5.
2. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Healthcare Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004;53(RR-3): 1-36.
3. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
4. Geckler RW, Gremillion DH, McAllister CK, Ellenbogen C. Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates. J Clin Microbiol. 1977;6:396-9.
5. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40: 373-83.
6. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336: 243-50.
7. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377-82.
8. Charles PG, Wolfe R, Whitby M, Fine MJ, Stirling R, Wright AA, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in communityacquired pneumonia. Clin Infect Dis. 2008;47:375-84.
9. Chalmers JD, Singanayagam A, Hill AT. Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia. Clin Infect Dis. 2008;47:1571-4.
10. The Japanese Respiratory Society. Guidelines for the management adults with hospital-acquired pneumonia. (in Japanese). http://www.jrs.or.jp/home/ modules/glsm/index.php?content-id=39.
11. Watanabe A, Yanagihara K, Kohno S, Matsushima T. Multicenter survey on hospital-acquired pneumonia and the clinical efficacy of first-line antibiotics in Japan. Intern Med. 2008;47: 245-54.
12. Schmitges J, Trinh Q-D, Bianchi M, Sun M, Abdollah F, Ahyai SA, et al. The effect of annual surgical caseload on the rates of inhospital pneumonia and other in-hospital outcomes after radical prostatectomy. International Urol Nephrol. http://www.springer link.com/content/970uj48047045h14/fulltext.html. Accessed 2011 Dec 13 (cited 2012 Mar 12) (Internet)
13. Davis KA, Eckert MJ, Reed RL 2nd, Esposito TJ, Santaniello JM, Poulakidas S, et al. Ventilator-associated pneumonia in injured patients: do you trust your Gram's stainJ Trauma. 2005;58: 462-6.
14. Raghavendran K, Wang J, Belber C, Misra SR, Brunton K, Berbary E, et al. Predictive value of sputum gram stain for the determination of appropriate antibiotic therapy in ventilatorassociated pneumonia. J Trauma. 2007;62:1377-82.
15. Goldberg AE, Malhotra AK, Riaz OJ, Aboutanos MB, Duane TM, Borchers CT, et al. Predictive value of broncho-alveolar lavage fluid Gram's stain in the diagnosis of ventilator-associated pneumonia: a prospective study. J Trauma. 2008;65:871-6.
16. Matsushima A, Tasaki O, Shimizu K, Tomono K, Ogura H, Shimazu T, et al. Preemptive antibiotic treatment based on gram staining reduced the incidence of ARDS in mechanically ventilated patients. J Trauma. 2008;65:309-15.
17. Albert M, Friedrich JO, Adhikari NK, Day AG, Verdant C, Heyland DK, et al. Utility of Gram stain in the clinical management of suspected ventilator-associated pneumonia. Secondary analysis of a multicenter randomized trial. J Crit Care. 2008; 23:74-81.
18. Mauri JM, Cléries M, Vela E, Registry CR. Design and validation of a model to predict early mortality in haemodialysis patients. Nephrol Dial Transpl. 2008;23(5):1690-6.
19. Maruyama T, Niederman MS, Kobayashi T, Kobayashi H, Takagi T, D'Alessandro-Gabazza CN, et al. A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respir Med. 2008;102:1287-95.
20. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-acquired Pneumonia in Adults. Clin Infect Dis. 2007;44:S27-72.
21. Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev. 2006;19: 637-57.